Advertisement

Topics

Roche Receives FDA Clearance for the VENTANA MMR IHC Panel for Patients Diagnosed With Colorectal...

19:00 EST 14 Nov 2017 | BioSpace

The tests detect certain proteins associated with a DNA repair mechanism called MMR, and aid in differentiating between sporadic colorectal cancer and probable Lynch syndrome, a hereditary form of colorectal cancer.

Original Article: Roche Receives FDA Clearance for the VENTANA MMR IHC Panel for Patients Diagnosed With Colorectal...

NEXT ARTICLE

More From BioPortfolio on "Roche Receives FDA Clearance for the VENTANA MMR IHC Panel for Patients Diagnosed With Colorectal..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Gastroenterology
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...